Safety Resources

Drug Recall & Withdrawal Notifications

A drug recall occurs when a medication is removed from the market because it is found to be either defective or potentially harmful. The FDA along with pharmaceutical companies monitors medications out on the market for unforeseen problems. If an issue is identified, or the safety of the medication becomes a concern, a recall is initiated.

 

Information provided below are important new safety information regarding drug recalls. If you are taking a medication that has been recalled, please talk to your health care providers about the best course of action.

  • Class I Recall: a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
  • Class II Recall: a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
  • Class III Recall: a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
  • Market Withdrawal: occurs when a product has a minor violation that would not be subject to FDA legal action. The firm removes the product from the market or corrects the violation. For example, a product removed from the market due to tampering, without evidence of manufacturing or distribution problems, would be a market withdrawal.

The hyperlinks below contain important new safety information regarding drug recalls. If you are taking a medication that has been recalled, please talk to your health care provider about the best course of action.

Drug Recall & Withdrawal Notifications - February 2024

Class I Recall – February 14, 2024

 

  • CVS Brand Multi Action Relief Drops (Polyvinyl alcohol 0.5%, Povidone 0.6%, Tetrahydrozoline 0.05%) 
  • CVS Health Brand Lubricant Eye Drops (Carboxymethylcellulose Sodium 0.5%)
  • CVS Health Brand Lubricant Eye Drops (Propylene glycol 0.6%)
  • CVS Health Brand Lubricant Gel Drops (Carboxymethylcellulose Sodium 1%) 
  • CVS Health Brand Lubricating Gel Drops (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%)
  • CVS Health Brand Mild Moderate Lubricating Eye Drops (Propylene glycol 400 0.25%)
  • EQUATE brand Hydration PF Lubricant Eye Drops (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%) 
  • Leader Brand Dry Eye Relief (Carboxymethylcellulose Sodium 1%),
  • Leader Brand Dry Eye Relief (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%)
  • Leader Brand Eye Irritation Relief (Polyvinyl alcohol 0.5%, Povidone 0.6%, Tetrahydrozoline 0.05%)
  • Leader Brand Lubricant Eye Drops (Carboxymethylcellulose Sodium 0.5%)
  • Leader Brand Lubricant Eye Drops (Propylene glycol Eye Drops 0.6%)
  • Lubricant Eye Drops (Carboxymethylcellulose Sodium 0.5%)
  • Lubricant Eye Drops (Propylene glycol 0.6%)
  • Lubricant Gel Drops (Carboxymethylcellulose sodium 1.0%)
  • Lubricant Gel Drops (Polyethylene glycol 400 0.4%, Propylene glycol 0.3%)
  • Multi-action Relief Drops (Polyvinyl alcohol 0.5%, Providone 0.6%, Tetrahydrozoline Hydrochloride 0.05%)
  • Rugby Brand Lubricating Tears Eye Drops (Dextran 70 0.1%, Hypromellose 2910 0.3%)
  • Rugby Brand Polyvinyl Alcohol 1.4% Lubricating Eye Drops
  • Target Brand High Performance Lubricant Eye Drops (Polyethylene glycol 400 0.4%, Propylene glycol 0.3%) 
  • Up&Up brand dry eye relief (Carboxymethylcellulose 0.5%) 
  • Velocity Pharma brand Lubricating Eye Drop (Propylene glycol Eye Drops 0.6%)

Class I - February 07, 2024

  • FentaNYL Citrate PF 1000 mcg per 100 mL 0.9% Sodium Chloride (10 mcg per mL)
  • FentaNYL Citrate PF 2500 mcg per 250 mL 0.9% Sodium Chloride (10 mcg per mL) 
  • PHENYLephrine HCl 20 mg per 250 mL 0.9% Sodium Chloride (80 mcg per mL) 
  • PHENYLephrine HCl 40 mg per 250 mL 0.9% Sodium Chloride (160 mcg per mL) 
  • VANCOmycin HCl PF 1.25g added to 0.9% Sodium Chloride 250 mL IV bag
  • VANCOmycin HCl PF 1.5g added to 0.9% Sodium Chloride 250 mL IV bag 

Ongoing Drug Recalls Archive